Skip to main content

Table 3 Hormonal profile

From: Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome – a prospective randomized double-blind clinical trial

 

Group 1 (n = 26)

Group 2 (n = 31)

P-value

Serum E2 day of trigger (pg/mL)

2479.7 ± 1345.0

2373.0 ± 892.2

0.77

Serum P day of trigger (ng/mL)

1.0 ± 0.4

0.9 ± 0.3

0.54

Serum LH day of trigger (mIU/mL)

2.1 ± 1.5

2.3 ± 2.3

0.76

Serum LH post trigger (mIU/mL)

75.0 ± 47.3

82.3 ± 50.0

0.57

Serum P post trigger (ng/mL)

5.5 ± 3.6

4.8 ± 2.3

0.61

Serum E2 5 days after trigger (pg/mL)

1576.0 ± 800.3

1914.0 ± 914.8

0.14

Serum E2 9 days after trigger (pg/mL)

468.8 ± 304.0

895.6 ± 456.8

< 0.01

Serum P 5 days after trigger (ng/mL)

122.1 ± 222.2

103.1 ± 42.7

0.67

Serum P 9 days after trigger (ng/mL)

29.9 ± 29.7

30.1 ± 19.1

0.98